#Variation	ClinVar Variation Id	Allele Registry Id	HGVS Expressions	HGNC Gene Symbol	Disease	Mondo Id	Mode of Inheritance	Assertion	Applied Evidence Codes (Met)	Applied Evidence Codes (Not Met)	Summary of interpretation	PubMed Articles	Expert Panel	Guideline	Approval Date	Published Date	Retracted	Evidence Repo Link	Uuid
NM_000277.2(PAH):c.1A>G (p.Met1Val)	586	CA114360	NM_000277.2:c.1A>G, NC_000012.12:g.102917130T>C, CM000674.2:g.102917130T>C, NC_000012.11:g.103310908T>C, CM000674.1:g.103310908T>C, NC_000012.10:g.101835038T>C, NG_008690.1:g.5473A>G, NG_008690.2:g.46281A>G, NM_000277.1:c.1A>G, XM_011538422.1:c.1A>G, NM_001354304.1:c.1A>G, XM_017019370.2:c.1A>G, NM_000277.3:c.1A>G, ENST00000307000.7:c.-147A>G, ENST00000546844.1:c.1A>G, ENST00000547319.1:n.312A>G, ENST00000549111.5:n.97A>G, ENST00000551337.5:c.1A>G, ENST00000551988.5:n.90A>G, ENST00000553106.5:c.1A>G, ENST00000635500.1:n.29-4232A>G, NM_000277.2(PAH):c.1A>G (p.Met1Val)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PP4_Moderate, PM2, PM3, PS3	PVS1	PAH-specific ACMG/AMP criteria applied: PM2: gnomAD MAF=0.00002; PP4_Moderate: Seen in PKU patients. BH4 disorders ruled out. (PMID:2574002); PS3: <3% (PMID:9450897). PM3: Detected in trans with known pathogenic variants. In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PM3, PP4_Moderate, PS3). Updated to reflect new PVS1 recommendations.	2574002, 2574002, 9450897	Phenylketonuria VCEP		2019-03-23	2019-05-10	false	https://erepo.genome.network/evrepo/ui/classification/CA114360/MONDO:0009861/006	89f04437-ed5d-4735-8c4a-a9b1d91d10ea
NM_000277.2(PAH):c.806delT (p.Ile269Thrfs)	102844	CA229778	NM_000277.2:c.806delT, NC_000012.12:g.102852851del, CM000674.2:g.102852851del, NC_000012.11:g.103246629del, CM000674.1:g.103246629del, NC_000012.10:g.101770759del, NG_008690.1:g.69752del, NG_008690.2:g.110560del, NM_000277.1:c.806del, XM_011538422.1:c.806del, NM_000277.2:c.806del, NM_001354304.1:c.806del, NM_000277.3:c.806del, ENST00000307000.7:c.791del, ENST00000549247.6:n.565del, ENST00000553106.5:c.806del, NM_000277.2(PAH):c.806delT (p.Ile269Thrfs)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PP4, PVS1, PM2		PAH-specific ACMG/AMP criteria applied: PVS1: Frameshift variant; PM2: Extremely low frequency. gnomAD MAF=0.00007.; PP4: Detected in a PKU patient. BH4 deficiency not assessed. (PMID:9012412). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PM2, PP4).	9012412	Phenylketonuria VCEP		2018-08-10	2019-08-17	false	https://erepo.genome.network/evrepo/ui/classification/CA229778/MONDO:0009861/006	f5d8dc3f-dba0-4dc9-98cd-4a22b6a11a83
NM_000277.2(PAH):c.561G>A (p.Trp187Ter)	102736	CA229624	NM_000277.2:c.561G>A, NC_000012.12:g.102855281C>T, CM000674.2:g.102855281C>T, NC_000012.11:g.103249059C>T, CM000674.1:g.103249059C>T, NC_000012.10:g.101773189C>T, NG_008690.1:g.67322G>A, NG_008690.2:g.108130G>A, NM_000277.1:c.561G>A, XM_011538422.1:c.561G>A, NM_001354304.1:c.561G>A, XM_017019370.2:c.561G>A, NM_000277.3:c.561G>A, ENST00000307000.7:c.546G>A, ENST00000549111.5:n.657G>A, ENST00000551988.5:n.582G>A, ENST00000553106.5:c.561G>A, NM_000277.2(PAH):c.561G>A (p.Trp187Ter)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PVS1, PP4_Moderate, PM2		PAH-specific ACMG/AMP criteria applied: PVS1: Nonsense variant; PM2: Extremely low frequency in gnomAD. MAF=0.00002.; PP4_Moderate: Detected in 3 chromosomes of patients with PAH deficiency. BH4 deficiency ruled out. (PMID:8268925). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PM2, PP4_Moderate).	8268925	Phenylketonuria VCEP		2018-08-10	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA229624/MONDO:0009861/006	c75a3cc6-1a5e-4837-b431-6e2b2a14c0b1
NM_000277.2(PAH):c.503delA (p.Tyr168Serfs)	102705	CA229588	NM_000277.2:c.503delA, NC_000012.12:g.102866602del, CM000674.2:g.102866602del, NC_000012.11:g.103260380del, CM000674.1:g.103260380del, NC_000012.10:g.101784510del, NG_008690.1:g.56001del, NG_008690.2:g.96809del, NM_000277.1:c.503del, XM_011538422.1:c.503del, NM_000277.2:c.503del, NM_001354304.1:c.503del, XM_017019370.2:c.503del, NM_000277.3:c.503del, ENST00000307000.7:c.488del, ENST00000549111.5:n.599del, ENST00000551988.5:n.530+10860del, ENST00000553106.5:c.503del, NM_000277.2(PAH):c.503delA (p.Tyr168Serfs)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PP4, PVS1, PM2		PAH-specific ACMG/AMP criteria applied: PVS1: Frameshift variant; PM2: Extremely low frequency. ExAC MAF: 0.00001.; PP4: Detected in PKU patient in international phase II clinical trial for sapropterin. (PMID:23430918). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PM2, PP4).	23430918	Phenylketonuria VCEP		2018-08-10	2019-08-17	false	https://erepo.genome.network/evrepo/ui/classification/CA229588/MONDO:0009861/006	7a494430-377e-4473-a5f7-e0698ec51cab
NM_000277.2(PAH):c.1089delG (p.Lys363Asnfs)	102518	CA229336	NM_000277.2:c.1089delG, NC_000012.12:g.102843756del, CM000674.2:g.102843756del, NC_000012.11:g.103237534del, CM000674.1:g.103237534del, NC_000012.10:g.101761664del, NG_008690.1:g.78847del, NG_008690.2:g.119655del, NM_000277.1:c.1089del, XM_011538422.1:c.1032del, NM_000277.2:c.1089del, NM_001354304.1:c.1089del, NM_000277.3:c.1089del, ENST00000307000.7:c.1074del, ENST00000549247.6:n.848del, ENST00000551114.2:n.751del, ENST00000553106.5:c.1089del, ENST00000635477.1:n.193del, ENST00000635528.1:n.604del, NM_000277.2(PAH):c.1089delG (p.Lys363Asnfs)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PP4, PVS1, PM2		PAH-specific ACMG/AMP criteria applied: PVS1: Frameshift variant; PM2: Absent from ExAC, gnomAD, 1000G, ESP; PP4: Detected in a patient with Classical PKU. (PMID:8659548). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PM2, PP4).	8659548	Phenylketonuria VCEP		2018-08-10	2019-08-17	false	https://erepo.genome.network/evrepo/ui/classification/CA229336/MONDO:0009861/006	f73ce257-c08b-40ce-845f-012c6403252c
NM_000277.2(PAH):c.1055delG (p.Gly352Valfs)	102498	CA229311	NM_000277.2:c.1055delG, NC_000012.12:g.102844347del, CM000674.2:g.102844347del, NC_000012.11:g.103238125del, CM000674.1:g.103238125del, NC_000012.10:g.101762255del, NG_008690.1:g.78257del, NG_008690.2:g.119065del, NM_000277.1:c.1055del, XM_011538422.1:c.998del, NM_000277.2:c.1055del, NM_001354304.1:c.1055del, NM_000277.3:c.1055del, ENST00000307000.7:c.1040del, ENST00000549247.6:n.814del, ENST00000551114.2:n.717del, ENST00000553106.5:c.1055del, ENST00000635477.1:n.159del, ENST00000635528.1:n.570del, NM_000277.2(PAH):c.1055delG (p.Gly352Valfs)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PP4, PVS1, PM2		PAH-specific ACMG/AMP criteria applied: PVS1: Frameshift variant; PM2: Extremely low frequency in ExAC, MAF=0.00002.; PP4: Identified in a pair of siblings with PKU. (PMID:7913581). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PM2, PP4).	7913581	Phenylketonuria VCEP		2018-08-10	2019-08-17	false	https://erepo.genome.network/evrepo/ui/classification/CA229311/MONDO:0009861/006	65776af0-77ed-41ec-9999-612a44a636b2
NM_000277.2(PAH):c.1024delG (p.Ala342Hisfs)	102475	CA229279	NM_000277.2:c.1024delG, NC_000012.12:g.102844378del, CM000674.2:g.102844378del, NC_000012.11:g.103238156del, CM000674.1:g.103238156del, NC_000012.10:g.101762286del, NG_008690.1:g.78226del, NG_008690.2:g.119034del, NM_000277.1:c.1024del, XM_011538422.1:c.967del, NM_000277.2:c.1024del, NM_001354304.1:c.1024del, NM_000277.3:c.1024del, ENST00000307000.7:c.1009del, ENST00000549247.6:n.783del, ENST00000551114.2:n.686del, ENST00000553106.5:c.1024del, ENST00000635477.1:n.128del, ENST00000635528.1:n.539del, NM_000277.2(PAH):c.1024delG (p.Ala342Hisfs)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PVS1, PP4_Moderate, PM2		PAH-specific ACMG/AMP criteria applied: PM2: Absent from ExAC, gnomAD, 1000G, ESP; PVS1: Frameshift variant; PP4_Moderate: Reported in patients with PAH deficiency. Bh4 defects excluded. (PMID:9634518). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PVS1, PP4_Moderate).	9634518	Phenylketonuria VCEP		2018-08-10	2019-08-17	false	https://erepo.genome.network/evrepo/ui/classification/CA229279/MONDO:0009861/006	4cc2d322-d860-4209-b3df-63e58bac3b07
NM_000277.2(PAH):c.912+1G>A	92752	CA220591	NM_000277.2:c.912+1G>A, NC_000012.12:g.102851686C>T, CM000674.2:g.102851686C>T, NC_000012.11:g.103245464C>T, CM000674.1:g.103245464C>T, NC_000012.10:g.101769594C>T, NG_008690.1:g.70917G>A, NG_008690.2:g.111725G>A, NM_000277.1:c.912+1G>A, XM_011538422.1:c.912+1G>A, NM_001354304.1:c.912+1G>A, NM_000277.3:c.912+1G>A, ENST00000307000.7:c.897+1G>A, ENST00000549247.6:n.671+1G>A, ENST00000551114.2:n.574+1G>A, ENST00000553106.5:c.912+1G>A, ENST00000635477.1:n.73+1G>A, NM_000277.2(PAH):c.912+1G>A	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PP4, PVS1, PM2		PAH-specific ACMG/AMP criteria applied: PM2: Extremely low frequency. ExAC MAF=0.00006.; PVS1: Canonical +1 splice site; PP4: Detected in 5 patients with classical PKU. (PMID:8659548). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PVS1, PP4).	8659548	Phenylketonuria VCEP		2018-08-10	2019-08-17	false	https://erepo.genome.network/evrepo/ui/classification/CA220591/MONDO:0009861/006	f8b8c165-463e-4138-88c6-316879bdcf67
NM_000277.2(PAH):c.331C>T (p.Arg111Ter)	581	CA251526	NM_000277.2:c.331C>T, NC_000012.12:g.102894756G>A, CM000674.2:g.102894756G>A, NC_000012.11:g.103288534G>A, CM000674.1:g.103288534G>A, NC_000012.10:g.101812664G>A, NG_008690.1:g.27847C>T, NG_008690.2:g.68655C>T, NM_000277.1:c.331C>T, XM_011538422.1:c.331C>T, NM_001354304.1:c.331C>T, XM_017019370.2:c.331C>T, NM_000277.3:c.331C>T, ENST00000307000.7:c.316C>T, ENST00000546844.1:c.331C>T, ENST00000548928.1:n.253C>T, ENST00000549111.5:n.427C>T, ENST00000550978.6:n.315C>T, ENST00000551337.5:c.331C>T, ENST00000551988.5:n.420C>T, ENST00000553106.5:c.331C>T, NM_000277.2(PAH):c.331C>T (p.Arg111Ter)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PM3_Very Strong, PP4_Moderate, PVS1	PM2	PAH-specific ACMG/AMP criteria applied: PVS1: Nonsense variant; PP4_Moderate: Seen in multiple Chinese PKU patients. BH4 deficiency excluded. (PMID:1301187; PMID:2816939; PMID:9860305); PM3_very-strong: Detected in trans with 6 known pathogenic variants: p.R158Q; p.R241C; p.R243Q; p.E280K; p.Y356*; p.R413P (PMID:15503242, 26322415). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PP4_Moderate, PM3_very-strong).	26322415, 15503242, 9860305, 1301187, 2816939	Phenylketonuria VCEP		2019-04-09	2019-04-09	false	https://erepo.genome.network/evrepo/ui/classification/CA251526/MONDO:0009861/006	a0f4f502-3d14-496e-92b6-b2160d5d9013
NM_000277.2(PAH):c.472C>T (p.Arg158Trp)	102693	CA229570	NM_000277.2:c.472C>T, NC_000012.12:g.102866633G>A, CM000674.2:g.102866633G>A, NC_000012.11:g.103260411G>A, CM000674.1:g.103260411G>A, NC_000012.10:g.101784541G>A, NG_008690.1:g.55970C>T, NG_008690.2:g.96778C>T, NM_000277.1:c.472C>T, XM_011538422.1:c.472C>T, NM_001354304.1:c.472C>T, XM_017019370.2:c.472C>T, NM_000277.3:c.472C>T, ENST00000307000.7:c.457C>T, ENST00000549111.5:n.568C>T, ENST00000551988.5:n.530+10829C>T, ENST00000553106.5:c.472C>T, NM_000277.2(PAH):c.472C>T (p.Arg158Trp)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PP3, PP4_Moderate, PM2, PS3, PM3_Strong		PAH-specific ACMG/AMP criteria applied: PM2: Extremely low frequency. ExAC MAF=0.00019.; PP3: Predicted deleterious in SIFT, Polyphen-2, MutationTaster. REVEL=0.939; PS3: 2% mutant enzyme activity in BioPKU; PP4_Moderate: Detected in at least 3 patients with PAH deficiency. BH4 deficiency ruled out in 1 patient. (PMID:1307609; PMID:10429004; PMID:9634518); PM3_Strong: Detected with 3 pathogenic/likely pathogenic variants (PMID:14681498; PMID:23430918). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP3, PS3, PP4_Moderate, PM3_Strong).	9634518, 1307609, 10429004, 23430918, 14681498	Phenylketonuria VCEP		2018-08-10	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA229570/MONDO:0009861/006	faad1844-5076-4b6f-b671-eeb06035449a
NM_000277.2(PAH):c.526C>T (p.Arg176Ter)	102723	CA275338	NM_000277.2:c.526C>T, NC_000012.12:g.102855316G>A, CM000674.2:g.102855316G>A, NC_000012.11:g.103249094G>A, CM000674.1:g.103249094G>A, NC_000012.10:g.101773224G>A, NG_008690.1:g.67287C>T, NG_008690.2:g.108095C>T, NM_000277.1:c.526C>T, XM_011538422.1:c.526C>T, NM_001354304.1:c.526C>T, XM_017019370.2:c.526C>T, NM_000277.3:c.526C>T, ENST00000307000.7:c.511C>T, ENST00000549111.5:n.622C>T, ENST00000551988.5:n.547C>T, ENST00000553106.5:c.526C>T, NM_000277.2(PAH):c.526C>T (p.Arg176Ter)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PVS1, PM2, PP4_Moderate, PM3_Strong		PAH-specific ACMG/AMP criteria applied: PVS1: Nonsense variant; PM2: ExAC MAF: 0.00010; PP4_Moderate: BH4 defect excluded in all patients in Liu 2015. Identified in 6 patients in this study (PMID:10394930; PMID:26600521); PM3_Strong: Identified in 6 patients, in trans with R243Q and R241C (both pathogenic) (PMID:26600521). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PM2, PP4_Moderate, PM3_Strong).	10394930, 26600521, 26600521	Phenylketonuria VCEP		2018-08-13	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA275338/MONDO:0009861/006	08d51386-af9e-4de1-8e7b-0dc6c2252c91
NM_000277.2(PAH):c.169G>A (p.Glu57Lys)	92737	CA220578	NM_000277.2:c.169G>A, NC_000012.12:g.102894918C>T, CM000674.2:g.102894918C>T, NC_000012.11:g.103288696C>T, CM000674.1:g.103288696C>T, NC_000012.10:g.101812826C>T, NG_008690.1:g.27685G>A, NG_008690.2:g.68493G>A, NM_000277.1:c.169G>A, XM_011538422.1:c.169G>A, NM_001354304.1:c.169G>A, XM_017019370.2:c.169G>A, NM_000277.3:c.169G>A, ENST00000307000.7:c.154G>A, ENST00000546844.1:c.169G>A, ENST00000548677.2:n.256G>A, ENST00000548928.1:n.91G>A, ENST00000549111.5:n.265G>A, ENST00000550978.6:n.153G>A, ENST00000551337.5:c.169G>A, ENST00000551988.5:n.258G>A, ENST00000553106.5:c.169G>A, ENST00000635500.1:n.137G>A, NM_000277.2(PAH):c.169G>A (p.Glu57Lys)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Uncertain Significance	PM2, PP4_Moderate, PM3_Supporting	PP3	PAH-specific ACMG/AMP criteria applied: PM2: Extremely low frequency. ESP MAF=0.00012.; PP4_Moderate: Detected in a patient with mild HPA. Assessment of the PAH, PTS, and QDPR genes was performed. (PMID:21147011); PM3-supporting: Detected with V388M, pathogenic in ClinVar, but parental testing not performed. (PMID:21147011). In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP4_Moderate, PM3_supporting).	21147011, 21147011	Phenylketonuria VCEP		2019-04-26	2019-04-26	false	https://erepo.genome.network/evrepo/ui/classification/CA220578/MONDO:0009861/006	1afec1b2-0d05-412d-b7b8-5253350ff838
NM_000277.2(PAH):c.581T>C (p.Leu194Pro)	102742	CA229633	NM_000277.2:c.581T>C, NC_000012.12:g.102855261A>G, CM000674.2:g.102855261A>G, NC_000012.11:g.103249039A>G, CM000674.1:g.103249039A>G, NC_000012.10:g.101773169A>G, NG_008690.1:g.67342T>C, NG_008690.2:g.108150T>C, NM_000277.1:c.581T>C, XM_011538422.1:c.581T>C, NM_001354304.1:c.581T>C, XM_017019370.2:c.581T>C, NM_000277.3:c.581T>C, ENST00000307000.7:c.566T>C, ENST00000549111.5:n.677T>C, ENST00000553106.5:c.581T>C, NM_000277.2(PAH):c.581T>C (p.Leu194Pro)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Likely Pathogenic	PP3, PP4_Moderate, PM2, PM3_Strong		PAH-specific ACMG/AMP criteria applied: PM2: Absent from 1000G, ESP. gnomAD MAF:0.00004.; PP3: Predicted deleterious in SIFT, Polyphen-2, MutationTaster. REVEL=0.899; PM3_Strong: Detected in trans with V245A and R261X, both pathogenic (PMID:7981714; PMID:16601866); PP4_Moderate: Detected in 3 patients (1 HPA, 1 PKU). BH4 deficiency excluded in 2 patients. (PMID:8533759; PMID:7981714; PMID:9012412; PMID:16601866). In summary this variant meets criteria to be classified as likely pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP3, PM3_Strong, PP4_Moderate).	9012412, 16601866, 8533759, 7981714, 16601866, 7981714	Phenylketonuria VCEP		2018-08-13	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA229633/MONDO:0009861/006	434f1539-4967-4ff7-abc2-e2ff3ca9ecbe
NM_000277.2(PAH):c.533A>G (p.Glu178Gly)	92746	CA273110	NM_000277.2:c.533A>G, NC_000012.12:g.102855309T>C, CM000674.2:g.102855309T>C, NC_000012.11:g.103249087T>C, CM000674.1:g.103249087T>C, NC_000012.10:g.101773217T>C, NG_008690.1:g.67294A>G, NG_008690.2:g.108102A>G, NM_000277.1:c.533A>G, XM_011538422.1:c.533A>G, NM_001354304.1:c.533A>G, XM_017019370.2:c.533A>G, NM_000277.3:c.533A>G, ENST00000307000.7:c.518A>G, ENST00000549111.5:n.629A>G, ENST00000551988.5:n.554A>G, ENST00000553106.5:c.533A>G, NM_000277.2(PAH):c.533A>G (p.Glu178Gly)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PP3, PP4_Moderate, PM2, PS3, PM3_Strong		PAH-specific ACMG/AMP criteria applied: PM2: Absent from 1000G, ESP. ExAC MAF=0.00017; PP3: Deleterious effect predicted in SIFT, Polyphen2, MutationTaster. REVEL=0.841; PS3: 39% residual phenylalanine hydroxylase activity (PMID:17935162); PP4_Moderate: Detected in 6 PKU patients. BH4 deficiency excluded. Upgraded per ClinGen PAHEP. (PMID:18294361; PMID:9634518); PM3_Strong: In trans with 3 pathogenic variants (PMID:18294361). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP3, PS3, PP4_Moderate, PM3_Strong).	9634518, 18294361, 17935162, 18294361	Phenylketonuria VCEP		2018-08-10	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA273110/MONDO:0009861/006	9cbb36d6-2daf-4507-b947-3a692ec4d9e7
NM_000277.2(PAH):c.1242C>T (p.Tyr414=)	102577	CA200893	NM_000277.2:c.1242C>T, NC_000012.12:g.102840473G>A, CM000674.2:g.102840473G>A, NC_000012.11:g.103234251G>A, CM000674.1:g.103234251G>A, NC_000012.10:g.101758381G>A, NG_008690.1:g.82130C>T, NG_008690.2:g.122938C>T, NM_000277.1:c.1242C>T, XM_011538422.1:c.1185C>T, NM_001354304.1:c.1242C>T, NM_000277.3:c.1242C>T, ENST00000307000.7:c.1227C>T, ENST00000551114.2:n.904C>T, ENST00000553106.5:c.1242C>T, ENST00000635477.1:n.346C>T, ENST00000635528.1:n.757C>T, NM_000277.2(PAH):c.1242C>T (p.Tyr414=)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Benign	BS2, BS1	BP4	PAH-specific ACMG/AMP criteria applied: BS1: MAF=0.01361 in ENF from gnomAD; BS2: 19 homozygotes in gnomAD. In summary this variant meets criteria to be classified as benign for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (BS1, BS2).		Phenylketonuria VCEP		2018-08-10	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA200893/MONDO:0009861/006	349736d7-05a8-4ec0-9b30-04fa24dd5529
NM_000277.2(PAH):c.1278T>C (p.Asn426=)	92732	CA145978	NM_000277.2:c.1278T>C, NC_000012.12:g.102840437A>G, CM000674.2:g.102840437A>G, NC_000012.11:g.103234215A>G, CM000674.1:g.103234215A>G, NC_000012.10:g.101758345A>G, NG_008690.1:g.82166T>C, NG_008690.2:g.122974T>C, NM_000277.1:c.1278T>C, XM_011538422.1:c.1221T>C, NM_001354304.1:c.1278T>C, NM_000277.3:c.1278T>C, ENST00000307000.7:c.1263T>C, ENST00000551114.2:n.940T>C, ENST00000553106.5:c.1278T>C, ENST00000635477.1:n.382T>C, ENST00000635528.1:n.793T>C, NM_000277.2(PAH):c.1278T>C (p.Asn426=)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Benign	BP4, BA1		PAH-specific ACMG/AMP criteria applied: BA1: MAF=0.16641; BP4: no impact on gene in SIFT, Polyphen2, MutationTaster. In summary this variant meets criteria to be classified as benign for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (BA1, BP4).		Phenylketonuria VCEP		2018-08-10	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA145978/MONDO:0009861/006	66eeb668-a8a7-49cb-a6cd-26afcc800972
NM_000277.2(PAH):c.355C>T (p.Pro119Ser)	92741	CA220582	NM_000277.2:c.355C>T, NC_000012.12:g.102877548G>A, CM000674.2:g.102877548G>A, NC_000012.11:g.103271326G>A, CM000674.1:g.103271326G>A, NC_000012.10:g.101795456G>A, NG_008690.1:g.45055C>T, NG_008690.2:g.85863C>T, NM_000277.1:c.355C>T, XM_011538422.1:c.355C>T, NM_001354304.1:c.355C>T, XM_017019370.2:c.355C>T, NM_000277.3:c.355C>T, ENST00000307000.7:c.340C>T, ENST00000549111.5:n.451C>T, ENST00000550978.6:n.339C>T, ENST00000551337.5:c.355C>T, ENST00000551988.5:n.444C>T, ENST00000553106.5:c.355C>T, NM_000277.2(PAH):c.355C>T (p.Pro119Ser)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Likely Pathogenic	PP3, PP4_Moderate, PM3_Strong	PM2	PAH-specific ACMG/AMP criteria applied: PP3: in silico analysis supportive of damaging effect; PM3_Strong: In trans with R261Q (PMID 21147011), and in trans with IVS2+1G>A (PMID 12655554) (PMID:21147011; PMID:12655554); PP4_Moderate: BH4 deficiency excluded (PMID:21147011). In summary this variant meets criteria to be classified as likely pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PP3, PM3_Strong, PP4_Moderate).	21147011, 12655554, 21147011	Phenylketonuria VCEP		2018-07-29	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA220582/MONDO:0009861/006	38a183ee-7e53-4c24-a250-50958f390c78
NM_000277.2(PAH):c.299A>G (p.His100Arg)	306914	CA6748985	NM_000277.2:c.299A>G, NC_000012.12:g.102894788T>C, CM000674.2:g.102894788T>C, NC_000012.11:g.103288566T>C, CM000674.1:g.103288566T>C, NC_000012.10:g.101812696T>C, NG_008690.1:g.27815A>G, NG_008690.2:g.68623A>G, NM_000277.1:c.299A>G, XM_011538422.1:c.299A>G, NM_001354304.1:c.299A>G, XM_017019370.2:c.299A>G, NM_000277.3:c.299A>G, ENST00000307000.7:c.284A>G, ENST00000546844.1:c.299A>G, ENST00000548928.1:n.221A>G, ENST00000549111.5:n.395A>G, ENST00000550978.6:n.283A>G, ENST00000551337.5:c.299A>G, ENST00000551988.5:n.388A>G, ENST00000553106.5:c.299A>G, NM_000277.2(PAH):c.299A>G (p.His100Arg)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Uncertain Significance	PP4, PM3, BP4	PM2	PAH-specific ACMG/AMP criteria applied: BP4: In silico overwhelmingly predict benign. REVEL = 0.553; PP4: Detected in a patient with non PKU hyperphe (PMID:11244681); PM3: H100R detected with IVS10 (PMID:11244681). In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (BP4, PP4, PM3).	11244681, 11244681	Phenylketonuria VCEP		2018-08-10	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA6748985/MONDO:0009861/006	a445bf0d-e08f-4300-b282-53c974544d50
NM_000277.1:c.772C>T	590340	CA6748843	NM_000277.1:c.772C>T, NC_000012.12:g.102852885G>A, CM000674.2:g.102852885G>A, NC_000012.11:g.103246663G>A, CM000674.1:g.103246663G>A, NC_000012.10:g.101770793G>A, NG_008690.1:g.69718C>T, NG_008690.2:g.110526C>T, XM_011538422.1:c.772C>T, NM_000277.2:c.772C>T, NM_001354304.1:c.772C>T, NM_000277.3:c.772C>T, ENST00000307000.7:c.757C>T, ENST00000549247.6:n.531C>T, ENST00000553106.5:c.772C>T	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Likely Benign	BS1, BP7	PM2	PAH-specific ACMG/AMP criteria applied: BS1: > PAH specific guidelines of AF-0.0002 (0.02%); BP7: No deleterious effect predicted.. In summary this variant meets criteria to be classified as likely benign for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (BS1, BP7).		Phenylketonuria VCEP		2018-08-13	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA6748843/MONDO:0009861/006	254ed141-a219-404a-8c94-1fd2aceb8103
NM_000277.2(PAH):c.963C>T (p.Leu321=)	102911	CA229873	NM_000277.2:c.963C>T, NC_000012.12:g.102846901G>A, CM000674.2:g.102846901G>A, NC_000012.11:g.103240679G>A, CM000674.1:g.103240679G>A, NC_000012.10:g.101764809G>A, NG_008690.1:g.75702C>T, NG_008690.2:g.116510C>T, NM_000277.1:c.963C>T, XM_011538422.1:c.913-2470C>T, NM_001354304.1:c.963C>T, NM_000277.3:c.963C>T, ENST00000307000.7:c.948C>T, ENST00000549247.6:n.722C>T, ENST00000551114.2:n.625C>T, ENST00000553106.5:c.963C>T, ENST00000635477.1:n.74-2470C>T, ENST00000635528.1:n.478C>T, NM_000277.2(PAH):c.963C>T (p.Leu321=)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Benign	BS2, BS3_Supporting, BS1, BP7		PAH-specific ACMG/AMP criteria applied: BS1: >0.02% as set by the PAH specific specifications; BP7: ; BS3_Supporting: cDNA method demonstrates 98% and intinic system demonstrates 81% residual enzyme activity; BS2: 38 homozygotes in gnomAD. In summary this variant meets criteria to be classified as benign for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (BS1, BP7, BS3_Supporting, BS2).		Phenylketonuria VCEP		2018-07-29	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA229873/MONDO:0009861/006	31e57f08-7be8-46c7-902d-8429b753f57c
NM_000277.2(PAH):c.500A>G (p.Asn167Ser)	102703	CA229585	NM_000277.2:c.500A>G, NC_000012.12:g.102866605T>C, CM000674.2:g.102866605T>C, NC_000012.11:g.103260383T>C, CM000674.1:g.103260383T>C, NC_000012.10:g.101784513T>C, NG_008690.1:g.55998A>G, NG_008690.2:g.96806A>G, NM_000277.1:c.500A>G, XM_011538422.1:c.500A>G, NM_001354304.1:c.500A>G, XM_017019370.2:c.500A>G, NM_000277.3:c.500A>G, ENST00000307000.7:c.485A>G, ENST00000549111.5:n.596A>G, ENST00000551988.5:n.530+10857A>G, ENST00000553106.5:c.500A>G, NM_000277.2(PAH):c.500A>G (p.Asn167Ser)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Uncertain Significance	PP4, BS1	PP3	PAH-specific ACMG/AMP criteria applied: PP4: N167S was observed in 1 case (genotype N167S/-) with benign persistent hyperphenylalaninemia (200-600 uM). (PMID:11385716); BS1: gnomAD MAF: 0.01461. In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PP4, BS1).	11385716	Phenylketonuria VCEP		2018-08-13	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA229585/MONDO:0009861/006	33e1f5d5-20ab-45d2-8dcd-4eba431a8642
NM_000277.2(PAH):c.464G>C (p.Arg155Pro)	102687	CA229561	NM_000277.2:c.464G>C, NC_000012.12:g.102866641C>G, CM000674.2:g.102866641C>G, NC_000012.11:g.103260419C>G, CM000674.1:g.103260419C>G, NC_000012.10:g.101784549C>G, NG_008690.1:g.55962G>C, NG_008690.2:g.96770G>C, NM_000277.1:c.464G>C, XM_011538422.1:c.464G>C, NM_001354304.1:c.464G>C, XM_017019370.2:c.464G>C, NM_000277.3:c.464G>C, ENST00000307000.7:c.449G>C, ENST00000549111.5:n.560G>C, ENST00000551988.5:n.530+10821G>C, ENST00000553106.5:c.464G>C, NM_000277.2(PAH):c.464G>C (p.Arg155Pro)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Likely Pathogenic	PP3, PP4_Moderate, PM2, PM3		PAH-specific ACMG/AMP criteria applied: PM2: absent from ExAC, gnomAD, 1000G, ESP. PAGE MAF=0.00066; PP3: Deleterious effect predicted in SIFT, Polyphen-2, MutationTaster. REVEL=0.967; PP4_Moderate: Detected in a patient with classic PKU. Cofactor deficiency excluded. (PMID:10679941); PM3: Detected in trans with R408W (P) (PMID:10679941). In summary this variant meets criteria to be classified as likely pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP3, PP4_Moderate, PM3).	10679941, 10679941	Phenylketonuria VCEP		2018-08-10	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA229561/MONDO:0009861/006	a532eae1-862f-4d90-b69e-5e590a9f7512
NM_000277.2(PAH):c.511G>A (p.Gly171Arg)	102716	CA229598	NM_000277.2:c.511G>A, NC_000012.12:g.102855331C>T, CM000674.2:g.102855331C>T, NC_000012.11:g.103249109C>T, CM000674.1:g.103249109C>T, NC_000012.10:g.101773239C>T, NG_008690.1:g.67272G>A, NG_008690.2:g.108080G>A, NM_000277.1:c.511G>A, XM_011538422.1:c.511G>A, NM_001354304.1:c.511G>A, XM_017019370.2:c.511G>A, NM_000277.3:c.511G>A, ENST00000307000.7:c.496G>A, ENST00000549111.5:n.607G>A, ENST00000551988.5:n.532G>A, ENST00000553106.5:c.511G>A, NM_000277.2(PAH):c.511G>A (p.Gly171Arg)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Likely Pathogenic	PP3, PM2, PP4_Moderate, PM3_Strong		PAH-specific ACMG/AMP criteria applied: PM2: Absent from ExAC, gnomAD, 1000G, ESP; PP3: Deleterious effect predicted in SIFT, Polyphen-2, MutationTaster. REVEL=0.966; PP4_Moderate: Detected in PKU patients. BH4 deficiency assessed. Upgraded per ClinGen PAH EP. (PMID:26600521; PMID:23430918); PM3_Strong: Detected with c.611A>G (P/LP) and R408W (P). Upgraded per ClinGen SVI workgroup. (PMID:23430918; PMID:26600521). In summary this variant meets criteria to be classified as likely pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP3, PP4_Moderate, PM3_Strong).	23430918, 26600521, 26600521, 23430918	Phenylketonuria VCEP		2018-08-10	2019-05-04	false	https://erepo.genome.network/evrepo/ui/classification/CA229598/MONDO:0009861/006	0dbfb1dc-9c9b-4fbe-b1a1-37b190aafe51
NM_000277.2(PAH):c.158G>A (p.Arg53His)	102601	CA229447	NM_000277.2:c.158G>A, NC_000012.12:g.102912801C>T, CM000674.2:g.102912801C>T, NC_000012.11:g.103306579C>T, CM000674.1:g.103306579C>T, NC_000012.10:g.101830709C>T, NG_008690.1:g.9802G>A, NG_008690.2:g.50610G>A, NM_000277.1:c.158G>A, XM_011538422.1:c.158G>A, NM_001354304.1:c.158G>A, XM_017019370.2:c.158G>A, NM_000277.3:c.158G>A, ENST00000307000.7:c.143G>A, ENST00000546844.1:c.158G>A, ENST00000548677.2:n.245G>A, ENST00000548928.1:n.80G>A, ENST00000549111.5:n.254G>A, ENST00000550978.6:n.142G>A, ENST00000551337.5:c.158G>A, ENST00000551988.5:n.247G>A, ENST00000553106.5:c.158G>A, ENST00000635500.1:n.126G>A, NM_000277.2(PAH):c.158G>A (p.Arg53His)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Uncertain Significance	PP4_Moderate, PM3, BS1	PP3	PAH-specific ACMG/AMP criteria applied: BS1: MAF=0.01596 in ExAC (138/8648) and 0.0104 in gnomAD (265/18868 with 3 homozygotes); PP4_moderate: Detected in multiple patients with hyperphenylalaninemia, BH4 deficiency excluded (PMID:24401910, 26322415); PM3: Detected in trans with pathogenic variant p.R243Q. In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (BS1, PP4_moderate, PM3).	24401910, 26322415, 24401910, 26322415	Phenylketonuria VCEP		2019-04-08	2019-04-08	false	https://erepo.genome.network/evrepo/ui/classification/CA229447/MONDO:0009861/006	0b0aa28d-6844-4b34-a270-410f26ce9504
NM_000277.2(PAH):c.535T>A (p.Tyr179Asn)	102729	CA229613	NM_000277.2:c.535T>A, NC_000012.12:g.102855307A>T, CM000674.2:g.102855307A>T, NC_000012.11:g.103249085A>T, CM000674.1:g.103249085A>T, NC_000012.10:g.101773215A>T, NG_008690.1:g.67296T>A, NG_008690.2:g.108104T>A, NM_000277.1:c.535T>A, XM_011538422.1:c.535T>A, NM_001354304.1:c.535T>A, XM_017019370.2:c.535T>A, NM_000277.3:c.535T>A, ENST00000307000.7:c.520T>A, ENST00000549111.5:n.631T>A, ENST00000551988.5:n.556T>A, ENST00000553106.5:c.535T>A, NM_000277.2(PAH):c.535T>A (p.Tyr179Asn)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Likely Pathogenic	PP3, PP4_Moderate, PM2, PM3		PAH-specific ACMG/AMP criteria applied: PM2: Absent from ExAC, gnomAD, 1000G, ESP; PP3: Deleterious effect predicted in SIFT, Polyphen-2, MutationTaster. REVEL=0.929; PP4_Moderate: Detected in 1 PKU patient, primary BH4 deficiency excluded. Upgraded per ClinGen PAH EP. (PMID:23430918); PM3: Detected with c.1066-11G>A (P) (PMID:23430918). In summary this variant meets criteria to be classified as likely pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP3, PP4_Moderate, PM3).	23430918, 23430918	Phenylketonuria VCEP		2018-08-10	2019-08-17	false	https://erepo.genome.network/evrepo/ui/classification/CA229613/MONDO:0009861/006	1530f57a-9096-4f98-a934-15ce8f576c73
NM_000277.2(PAH):c.842+3G>C	102871	CA229814	NM_000277.2:c.842+3G>C, NC_000012.12:g.102852812C>G, CM000674.2:g.102852812C>G, NC_000012.11:g.103246590C>G, CM000674.1:g.103246590C>G, NC_000012.10:g.101770720C>G, NG_008690.1:g.69791G>C, NG_008690.2:g.110599G>C, NM_000277.1:c.842+3G>C, XM_011538422.1:c.842+3G>C, NM_001354304.1:c.842+3G>C, NM_000277.3:c.842+3G>C, ENST00000307000.7:c.827+3G>C, ENST00000549247.6:n.601+3G>C, ENST00000553106.5:c.842+3G>C, ENST00000635477.1:n.3+3G>C, NM_000277.2(PAH):c.842+3G>C	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Likely Pathogenic	PP4_Moderate, PM2, PM3_Strong		PAH-specific ACMG/AMP criteria applied: PM2: Extremely low frequency in gnomAD+ExAC (MAF=0.00006). Absent from 1000G, ESP.; PP4_Moderate: Detected in Costa Rican and 1 Spanish PKU patients, exclusion of defects in tetrahydrobiopterine metabolism. (PMID:8860005; PMID:8981952); PM3_Strong: Detected in trans with I269L and R408W, known pathogenic variants. (PMID:9521426; PMID:23430918). In summary this variant meets criteria to be classified as likely pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP4_Moderate, PM3_Strong).	8860005, 8981952, 9521426, 23430918	Phenylketonuria VCEP		2018-09-11	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA229814/MONDO:0009861/006	ad7649c8-a5c0-4598-8404-91fbd76346b9
NM_000277.2(PAH):c.500A>T (p.Asn167Ile)	92743	CA220584	NM_000277.2:c.500A>T, NC_000012.12:g.102866605T>A, CM000674.2:g.102866605T>A, NC_000012.11:g.103260383T>A, CM000674.1:g.103260383T>A, NC_000012.10:g.101784513T>A, NG_008690.1:g.55998A>T, NG_008690.2:g.96806A>T, NM_000277.1:c.500A>T, XM_011538422.1:c.500A>T, NM_001354304.1:c.500A>T, XM_017019370.2:c.500A>T, NM_000277.3:c.500A>T, ENST00000307000.7:c.485A>T, ENST00000549111.5:n.596A>T, ENST00000551988.5:n.530+10857A>T, ENST00000553106.5:c.500A>T, NM_000277.2(PAH):c.500A>T (p.Asn167Ile)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Likely Pathogenic	PP4_Moderate, PM2, PM3_Strong	PP3	PAH-specific ACMG/AMP criteria applied: PM2: Extremely low frequency in ExAC (MAF=0.00003). Absent from gnomAD, 1000G, ESP; PP4_Moderate: Found in a French patient with HPA and 2 unrelated UK patients. BH4 deficiencies not assessed/reported. Seen in 1 German patient, Cofactor deficiency was excluded by the BH4 test. 1 Spanish patient, a defect in the synthesis or regeneration pathways of 6R-BH4 was ruled out by analyzing urinary pterin levels and measuring dihydropteridine reductase activity. (PMID:26666653; PMID:9012412; PMID:10679941); PM3_Strong: Patient 664 with genotype N167I/Rl58Q (Pathogenic in ClinVar). Detected with G272X and R408W, known pathogenic variants. (PMID:24368688; PMID:26666653). In summary this variant meets criteria to be classified as likely pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP4_Moderate, PM3_Strong).	9012412, 10679941, 26666653, 24368688, 26666653	Phenylketonuria VCEP		2018-08-28	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA220584/MONDO:0009861/006	a49cb655-9cb0-4fac-959d-26d4290227d6
NM_000277.2(PAH):c.506G>A (p.Arg169His)	102706	CA286505	NM_000277.2:c.506G>A, NC_000012.12:g.102866599C>T, CM000674.2:g.102866599C>T, NC_000012.11:g.103260377C>T, CM000674.1:g.103260377C>T, NC_000012.10:g.101784507C>T, NG_008690.1:g.56004G>A, NG_008690.2:g.96812G>A, NM_000277.1:c.506G>A, XM_011538422.1:c.506G>A, NM_001354304.1:c.506G>A, XM_017019370.2:c.506G>A, NM_000277.3:c.506G>A, ENST00000307000.7:c.491G>A, ENST00000549111.5:n.602G>A, ENST00000551988.5:n.530+10863G>A, ENST00000553106.5:c.506G>A, NM_000277.2(PAH):c.506G>A (p.Arg169His)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Likely Pathogenic	PP4_Moderate, PM3_Strong	PP3, PM2	PAH-specific ACMG/AMP criteria applied: PP4_Moderate: This variant has been reported in multiple mild hyperphenylalaninaemia (MHP) patients, with BH4 defects excluded. Upgraded per ClinGen Metabolic workgroup. (PMID:10234516); PM3_Strong: Detected with P281L and A403V, both pathogenic variants (PMID:10234516). In summary this variant meets criteria to be classified as likely pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PP4_Moderate, PM3_Strong).	10234516, 10234516	Phenylketonuria VCEP		2018-08-10	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA286505/MONDO:0009861/006	7b1098c0-cd76-4492-9b41-16cbd8f9ddc3
NM_000277.2(PAH):c.350C>T (p.Thr117Ile)	120273	CA267651	NM_000277.2:c.350C>T, NC_000012.12:g.102894737G>A, CM000674.2:g.102894737G>A, NC_000012.11:g.103288515G>A, CM000674.1:g.103288515G>A, NC_000012.10:g.101812645G>A, NG_008690.1:g.27866C>T, NG_008690.2:g.68674C>T, NM_000277.1:c.350C>T, XM_011538422.1:c.350C>T, NM_001354304.1:c.350C>T, XM_017019370.2:c.350C>T, NM_000277.3:c.350C>T, ENST00000307000.7:c.335C>T, ENST00000546844.1:c.350C>T, ENST00000548928.1:n.272C>T, ENST00000549111.5:n.446C>T, ENST00000550978.6:n.334C>T, ENST00000551337.5:c.350C>T, ENST00000551988.5:n.439C>T, ENST00000553106.5:c.350C>T, NM_000277.2(PAH):c.350C>T (p.Thr117Ile)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Uncertain Significance	PM2	PP3, PM5	PAH-specific ACMG/AMP criteria applied: PM2: Extremely low frequency in ExAC& gnomAD (MAF 0.00018). Absent from 1000G, ESP. In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2).		Phenylketonuria VCEP		2018-09-28	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA267651/MONDO:0009861/006	4112e5b8-c121-471a-a34f-9da03e769a2b
NM_000277.2(PAH):c.1068C>A (p.Tyr356Ter)	92729	CA273107	NM_000277.2:c.1068C>A, NC_000012.12:g.102843777G>T, CM000674.2:g.102843777G>T, NC_000012.11:g.103237555G>T, CM000674.1:g.103237555G>T, NC_000012.10:g.101761685G>T, NG_008690.1:g.78826C>A, NG_008690.2:g.119634C>A, NM_000277.1:c.1068C>A, XM_011538422.1:c.1011C>A, NM_001354304.1:c.1068C>A, NM_000277.3:c.1068C>A, ENST00000307000.7:c.1053C>A, ENST00000549247.6:n.827C>A, ENST00000551114.2:n.730C>A, ENST00000553106.5:c.1068C>A, ENST00000635477.1:n.172C>A, ENST00000635528.1:n.583C>A, NM_000277.2(PAH):c.1068C>A (p.Tyr356Ter)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PP4_Moderate, PM2, PVS1, PM3_Strong		PAH-specific ACMG/AMP criteria applied: PVS1: Nonsense variant; PM2: gnomAD MAF 0.00017; PP4_Moderate: Detected in PKU patients (PMID:25894915); PM3_Strong: in trans with p.W326X (Pathogenic), and IVS4-1G>A (Pathogenic). (PMID:25894915). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PM2, PP4_Moderate, PM3_Strong).	25894915, 25894915	Phenylketonuria VCEP		2018-08-13	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA273107/MONDO:0009861/006	6f390ad4-1675-4f3f-9b2d-eb81f608dc3b
NM_000277.2(PAH):c.818C>T (p.Ser273Phe)	598	CA229785	NM_000277.2:c.818C>T, NC_000012.12:g.102852839G>A, CM000674.2:g.102852839G>A, NC_000012.11:g.103246617G>A, CM000674.1:g.103246617G>A, NC_000012.10:g.101770747G>A, NG_008690.1:g.69764C>T, NG_008690.2:g.110572C>T, NM_000277.1:c.818C>T, XM_011538422.1:c.818C>T, NM_001354304.1:c.818C>T, NM_000277.3:c.818C>T, ENST00000307000.7:c.803C>T, ENST00000549247.6:n.577C>T, ENST00000553106.5:c.818C>T, NM_000277.2(PAH):c.818C>T (p.Ser273Phe)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Likely Pathogenic	PP3, PM2, PP4_Moderate, PM3_Strong	PM5	PAH-specific ACMG/AMP criteria applied: PM2: Extremely low frequency in ExAC and gnomAD (1 allele); PP3: Deleterious effect predicted in SIFT, Polyphen2, MutationTaster. REVEL=0.978; PP4_Moderate: S273F was detected in in Northern Ireland, Belgium/French, Western Scotland, and New South Wales PKU patients. BH4 deficiency was assessed in 1 study. Upgraded per ClinGen Metabolic workgroup. (PMID:1671881; PMID:8533759; PMID:9012412; PMID:24368688); PM3_Strong: Seen with 2 known pathogenic mutations: I65T, R408W. Upgraded based on SVI worgroup recommendations and approved PAH guidelines (PMID:24368688). In summary this variant meets criteria to be classified as likely pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP3, PP4_Moderate, PM3_Strong).	1671881, 24368688, 9012412, 8533759, 24368688	Phenylketonuria VCEP		2018-08-10	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA229785/MONDO:0009861/006	75b9eddc-e554-4f4c-91a7-976ac6c27ba2
NM_000277.2(PAH):c.194T>C (p.Ile65Thr)	636	CA251544	NM_000277.2:c.194T>C, NC_000012.12:g.102894893A>G, CM000674.2:g.102894893A>G, NC_000012.11:g.103288671A>G, CM000674.1:g.103288671A>G, NC_000012.10:g.101812801A>G, NG_008690.1:g.27710T>C, NG_008690.2:g.68518T>C, NM_000277.1:c.194T>C, XM_011538422.1:c.194T>C, NM_001354304.1:c.194T>C, XM_017019370.2:c.194T>C, NM_000277.3:c.194T>C, ENST00000307000.7:c.179T>C, ENST00000546844.1:c.194T>C, ENST00000548677.2:n.281T>C, ENST00000548928.1:n.116T>C, ENST00000549111.5:n.290T>C, ENST00000550978.6:n.178T>C, ENST00000551337.5:c.194T>C, ENST00000551988.5:n.283T>C, ENST00000553106.5:c.194T>C, ENST00000635500.1:n.162T>C, NM_000277.2(PAH):c.194T>C (p.Ile65Thr)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PP3, PM3_Very Strong, PP4_Moderate, PS3	PP1, PM2, PM5, PS1	PAH-specific ACMG/AMP criteria applied: PM3_VeryStrong: Detected with Y414C (P), R408W (P), P281L (P), IVS10nt-11 (P), R252W (P/LP), and R243Q(P). (PMID:12501224; PMID:1301201; PMID:10767174); PP3: Predicted dleterious in SIZFT, Polyphen2, MutationTaster. REVEL=0.985; PP4_Moderate: Detected in a patient with mild PKU. BH4 deficiency excluded. Upgraded per ClinGen PAH EP. (PMID:12501224); PS3: 25% mutant enzyme activity in COS cells as compared in wt (PMID:1301201). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM3_VeryStrong, PP3, PP4_Moderate, PS3).	10767174, 1301201, 12501224, 12501224, 21871829, 1301201	Phenylketonuria VCEP		2018-04-21	2019-04-08	true	https://erepo.genome.network/evrepo/ui/classification/CA251544/MONDO:0009861/006	633ef5e6-95c8-4ff5-88b2-6cf22b99158b
NM_000277.2(PAH):c.812A>T (p.His271Leu)	120287	CA267675	NM_000277.2:c.812A>T, NC_000012.12:g.102852845T>A, CM000674.2:g.102852845T>A, NC_000012.11:g.103246623T>A, CM000674.1:g.103246623T>A, NC_000012.10:g.101770753T>A, NG_008690.1:g.69758A>T, NG_008690.2:g.110566A>T, NM_000277.1:c.812A>T, XM_011538422.1:c.812A>T, NM_001354304.1:c.812A>T, NM_000277.3:c.812A>T, ENST00000307000.7:c.797A>T, ENST00000549247.6:n.571A>T, ENST00000553106.5:c.812A>T, NM_000277.2(PAH):c.812A>T (p.His271Leu)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Uncertain Significance	PP3, PP4_Moderate, PM2	PM5	PAH-specific ACMG/AMP criteria applied: PM2: Absent from ExAC, gnomAD, 1000G, ESP; PP3: Predicted deleterious in SIFT, Polyphen2, MutationTaster. REVEL=0.957; PP4_Moderate: H271L seen in a Chinese PKU patient. BH4 deficiencies excluded. Upgraded per ClinGen Metabolic workgroup. (PMID:26503515). In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP3, PP4_Moderate).	26503515	Phenylketonuria VCEP		2018-08-10	2019-04-05	false	https://erepo.genome.network/evrepo/ui/classification/CA267675/MONDO:0009861/006	d8dab33d-d9aa-45d0-8e54-f50e90d27dd5
NM_000277.2(PAH):c.310_318delGCCACTGTC (p.Ala104_Val106del)	92740	CA220580	NM_000277.2:c.310_318delGCCACTGTC, NC_000012.12:g.102894769_102894777del, CM000674.2:g.102894769_102894777del, NC_000012.11:g.103288547_103288555del, CM000674.1:g.103288547_103288555del, NC_000012.10:g.101812677_101812685del, NG_008690.1:g.27826_27834del, NG_008690.2:g.68634_68642del, NM_000277.1:c.310_318del, XM_011538422.1:c.310_318del, NM_000277.2:c.310_318del, NM_001354304.1:c.310_318del, XM_017019370.2:c.310_318del, NM_000277.3:c.310_318del, ENST00000307000.7:c.295_303del, ENST00000546844.1:c.310_318del, ENST00000548928.1:n.232_240del, ENST00000549111.5:n.406_414del, ENST00000550978.6:n.294_302del, ENST00000551337.5:c.310_318del, ENST00000551988.5:n.399_407del, ENST00000553106.5:c.310_318del, NM_000277.2(PAH):c.310_318delGCCACTGTC (p.Ala104_Val106del)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Uncertain Significance	PP4, PM2, PM4		PAH-specific ACMG/AMP criteria applied: PM2: Identified a single time in gnomAD (4.06e-06) and absent in ExAC; PM4: p.Ala104_Val106del; PP4: Single patient picked up on NBS with no confirmation studies, no clinical info, no Phe levels, etc. (PMID:27308838). In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PM4, PP4).	27308838	Phenylketonuria VCEP		2018-08-10	2019-08-17	false	https://erepo.genome.network/evrepo/ui/classification/CA220580/MONDO:0009861/006	6d2dd44e-13de-406f-a230-bfe8aa3f0740
NM_000277.2(PAH):c.205_210dup (p.Ser70_Arg71insProSer)	120271	CA267647	NM_000277.2:c.205_210dup, NM_000277.1:c.206_211dup, XM_011538422.1:c.206_211dup, NM_000277.2:c.206_211dup, NM_001354304.1:c.206_211dup, XM_017019370.2:c.206_211dup, NM_000277.3:c.206_211dup, ENST00000307000.7:c.191_196dup, ENST00000546844.1:c.206_211dup, ENST00000548677.2:n.293_298dup, ENST00000548928.1:n.128_133dup, ENST00000549111.5:n.302_307dup, ENST00000550978.6:n.190_195dup, ENST00000551337.5:c.206_211dup, ENST00000551988.5:n.295_300dup, ENST00000553106.5:c.206_211dup, ENST00000635500.1:n.174_179dup, NC_000012.12:g.102894877_102894882dup, CM000674.2:g.102894877_102894882dup, NC_000012.11:g.103288655_103288660dup, CM000674.1:g.103288655_103288660dup, NC_000012.10:g.101812785_101812790dup, NG_008690.1:g.27722_27727dup, NG_008690.2:g.68530_68535dup, NM_000277.2(PAH):c.205_210dup (p.Ser70_Arg71insProSer)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Uncertain Significance	PM2, PM4		PAH-specific ACMG/AMP criteria applied: PM2: chr12-103288654--GAGAAG; Absent from population databases; PM4: in-frame insertion. In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PM4).		Phenylketonuria VCEP		2018-08-10	2019-08-17	false	https://erepo.genome.network/evrepo/ui/classification/CA267647/MONDO:0009861/006	4b73962a-e05e-466d-b474-fa8e50ec1626
NM_000277.2(PAH):c.800A>T (p.Gln267Leu)	225135	CA354145	NM_000277.2:c.800A>T, NC_000012.12:g.102852857T>A, CM000674.2:g.102852857T>A, NC_000012.11:g.103246635T>A, CM000674.1:g.103246635T>A, NC_000012.10:g.101770765T>A, NG_008690.1:g.69746A>T, NG_008690.2:g.110554A>T, NM_000277.1:c.800A>T, XM_011538422.1:c.800A>T, NM_001354304.1:c.800A>T, NM_000277.3:c.800A>T, ENST00000307000.7:c.785A>T, ENST00000549247.6:n.559A>T, ENST00000553106.5:c.800A>T, NM_000277.2(PAH):c.800A>T (p.Gln267Leu)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Uncertain Significance	PP3, PM2, PP4_Moderate	PM5	PAH-specific ACMG/AMP criteria applied: PM2: Absent from 1000G, ESP. Extremely low frequency in ExAC and gnomAD ( 0.00001, 0.000004063); PP3: Predicted deleterious in SIFT, Polyphen2, MutationTaster. REVEL=0.975; PP4_Moderate: Q267L found in 1 Japanese PKU allele and in 1 Chinese PKU patient. Analysis of dihydropteridine reductase activity in red blood cells, biopterin loading test and/or pteridine analysis in urine was performed in the Japanese study. Upgraded per ClinGen Metabolic workgroup. (PMID:21307867; PMID:24078561; PMID:26503515). In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP3, PP4_Moderate).	21307867, 26503515, 24078561	Phenylketonuria VCEP		2018-08-10	2019-04-05	false	https://erepo.genome.network/evrepo/ui/classification/CA354145/MONDO:0009861/006	0f298658-69d4-402a-a0d1-47973a683451
